PROVIDER PROFILE · NPI 1083881544

Eugene RozenshteynMD

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$205

Distinct drugs

Brand share

100.0%

Top prescribed drugs

QUALITY · MIPS · 2024

Final MIPS score

97.6

Quality

79.6

Cost

81.2

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.95%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

Hospital

CROSS-REFERENCE